Overall and Disease-Specific Mortality in Patients With Cushing Disease: A Swedish Nationwide Study

Oskar Ragnarsson1,2, Daniel S Olsson1,2, Eleni Papakokkinou1,2

  • 1Department of Internal Medicine and Clinical Nutrition, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden.

Insights

Patients with Cushing disease (CD) have higher mortality rates, even in remission. Cardiovascular diseases, infections, and suicide are leading causes, highlighting the need for ongoing monitoring and management.

Area of Science:

  • Endocrinology
  • Epidemiology
  • Clinical Medicine

Background:

  • Cushing disease (CD) is a rare endocrine disorder caused by excess cortisol production.
  • The long-term mortality risk for patients with CD, particularly those in remission, remains incompletely understood.

Purpose of the Study:

  • To investigate overall and disease-specific mortality in a nationwide cohort of patients with Cushing disease.
  • To identify predictors of mortality in patients with CD.

Main Methods:

  • Retrospective analysis of patients diagnosed with CD between 1987 and 2013 in the Swedish National Patient Registry.
  • Systematic medical record review for diagnosis verification.
  • Calculation of standardized mortality ratios (SMRs) and Cox regression modeling.

Main Results:

  • The study included 502 patients with CD, 83% of whom achieved remission.
  • Overall mortality was significantly increased (SMR 2.5), with cardiovascular diseases being the most common cause of death.
  • In remission, mortality remained elevated (SMR 1.9), with bilateral adrenalectomy and glucocorticoid replacement linked to increased risk, while GH replacement showed a protective effect.

Conclusions:

  • Patients with Cushing disease experience excess mortality, underscoring the importance of achieving and maintaining remission.
  • Continued surveillance, adequate hormone replacement, and management of cardiovascular and mental health are crucial for improving outcomes in CD patients.
Abstract

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.0K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.4K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
579
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
944
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
540